CEO Amy Trombly amends employment agreement; COO Bruce Thornton retires, position eliminated

Sonoma Pharmaceuticals, Inc.

CEO Amy Trombly's base salary set at $475,000 per annum; target annual bonus of 50% of base salary.
CEO severance: termination without cause or for Good Reason: 1x base salary paid via payroll; COBRA up to 12 months.
CEO change-in-control severance: 2x base salary + 2x target bonus; COBRA up to 24 months.
COO Bruce Thornton to retire on Dec 2, 2025; position eliminated; severance $300,000 plus COBRA up to 12 months.
COO's time-based equity awards fully vest; performance-based awards remain per terms.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.